Nutrigenomics Market

Key Players: Companies such as Nutrigenomix (CA), DNAfit (GB), 23andMe (US), Genomind(US), Nutrigenomics Ltd (GB), Nutrigenomix Inc (CA), Genetic Health (US), Nutrigenomics Technologies (US) are some of the major participants in the global market.

Nutrigenomics Market

Nutrigenomics Market Research Report By Application (Personalized Nutrition, Disease Prevention, Health Optimization, Fitness and Athletic Performance), By End Use (Healthcare, Dietary Supplements, Food Beverage, Pharmaceuticals), By Product Type (Genetic Testing Kits, Bioinformatics Tools, Nutritional Analysis Software), By Technology (DNA Sequencing, Microarray Analysis, Polymerase Chain Reaction) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035
ID: MRFR/Pharma/2692-CR
94 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: June 19, 2026

Nutrigenomics Market Summary

Global Nutrigenomics Market Size was valued at USD 0.68 Billion in 2024 & the market is projected to grow from USD 0.799 Billion in 2025 to USD 4.008 Billion by 2035, registering a CAGR of 17.50% during the forecast period 2025–2035. North America led the market with over 45% share, generating around USD 0.3 Billion in revenue.
 
The growing demand for personalized nutrition based on individual genetic profiles is a major growth driver for the Nutrigenomics Market. Increasing consumer awareness of preventive healthcare, coupled with advances in genetic testing technologies, is encouraging the adoption of tailored dietary recommendations to improve long-term health outcomes.
 
According to the WHO, noncommunicable diseases account for approximately 41 million deaths annually, representing 74% of global deaths, increasing interest in personalized nutrition approaches that help individuals manage health risks through genetics-informed dietary interventions.

Key Market Trends & Highlights

The Nutrigenomics Market is experiencing robust growth driven by personalized nutrition and technological advancements.

  • North America accounted for over 44.12% of global Nutrigenomics Market revenue in 2024, maintaining regional leadership.
  • Europe generated USD 0.204 billion in revenue during 2024, representing approximately 30% of the global market.
  • Personalized Nutrition accounted for approximately 55% of application revenue in 2024, driven by increasing demand for genetics-based dietary guidance.
  • Healthcare represented nearly 60% of end-use revenue in 2024, reflecting strong adoption of nutrigenomics in preventive health management.
  • Genetic Testing Kits generated approximately 50% of product revenue in 2024, supported by rising consumer interest in genomic wellness insights.
  • DNA Sequencing captured around 55% of technology revenue in 2024, benefiting from advancing genomic technologies and declining analysis costs.

Market Size & Forecast

2024 Market Size 0.68 (USD Billion)
2035 Market Size 4.008 (USD Billion)
CAGR (2025 - 2035) 17.5%

Major Players

Companies such as Nutrigenomix (CA), DNAfit (GB), 23andMe (US), Genomind(US), Nutrigenomics Ltd (GB), Nutrigenomix Inc (CA), Genetic Health (US), Nutrigenomics Technologies (US) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Nutrigenomics Market Trends

The Nutrigenomics Market is currently experiencing a notable evolution, driven by advancements in genetic research and an increasing awareness of the relationship between diet and health. This sector appears to be gaining traction as consumers become more informed about personalized nutrition and its potential benefits. The integration of genetic nutrigenetics testing with dietary recommendations is fostering a new paradigm in health management, where individuals can tailor their diets based on their unique genetic profiles.

This shift suggests a growing demand for products and services that cater to personalized dietary needs, potentially transforming traditional approaches to nutrition and wellness. Moreover, the market seems poised for further growth as technological innovations continue to emerge. The rise of digital health platforms and mobile applications that facilitate genetic testing and personalized nutrition plans indicates a shift towards more accessible and user-friendly solutions.

As consumers increasingly seek out tailored health solutions, the nutrigenomics testing market may witness a surge in collaborations between biotechnology firms and nutrition companies. This collaborative approach could enhance the development of innovative products, thereby expanding the nutrigenomics testing market's reach and appeal to a broader audience. Overall, the market is on a trajectory that suggests a promising future, characterized by increased consumer engagement and technological advancements.

Personalized Nutrition Solutions

The market is witnessing a trend towards personalized nutrition solutions, where dietary recommendations are tailored to individual genetic profiles. This approach allows consumers to optimize their health by aligning their diets with their unique genetic makeup, potentially enhancing overall well-being.

  • Nutrigenomix continues advancing product development and innovation through genetic-based nutrition testing while expanding strategic partnerships and collaborations with healthcare practitioners globally. The company’s nutrigenomic platform analyzes 70+ genetic markers associated with nutrition and wellness, supporting highly personalized dietary recommendations. Growing consumer demand for individualized health solutions is accelerating adoption of nutrigenomics services and strengthening market expansion.

Technological Integration

The integration of advanced technologies, such as mobile applications and digital health platforms, is becoming increasingly prevalent in the market. These tools facilitate genetic testing and provide personalized dietary guidance, making it easier for consumers to access tailored nutrition solutions.

  • DNAfit has strengthened its market presence through portfolio expansion initiatives and ongoing advancements in consumer genetic services. Its digital platform integrates genetic insights with nutrition and fitness recommendations, supporting personalized wellness planning. Increasing use of mobile health technologies and digital platforms is enhancing accessibility to genetic testing services, enabling broader consumer engagement and accelerating nutrigenomics market growth.

Collaborative Innovations

There is a growing trend of collaboration between biotechnology firms and nutrition companies within the market. This partnership aims to develop innovative products that cater to personalized dietary needs, thereby expanding the nutrigenomics testing market's offerings and enhancing consumer engagement.

  • 23andMe continues investing in product development and innovation while benefiting from regulatory advancements supporting genetic testing services. The company has generated genetic insights from more than 14 million customers, creating extensive genomic datasets for personalized health applications. Growing collaboration between biotechnology firms and nutrition-focused organizations is accelerating innovation and expanding personalized nutrition offerings across global markets.

Nutrigenomics Market Drivers

Rising Health Awareness

The increasing awareness regarding health and wellness among consumers appears to be a pivotal driver for the Nutrigenomics Market. As individuals become more conscious of their dietary choices and their impact on health, the demand for personalized nutrition solutions is likely to surge. This trend is reflected in the growing interest in genetic testing and its implications for tailored dietary recommendations.
 
According to recent data, the market for personalized nutrition is projected to reach substantial figures, indicating a robust growth trajectory. Consumers are increasingly seeking products that align with their genetic profiles, thereby propelling the market forward. This heightened focus on health is not merely a passing trend; it suggests a fundamental shift in consumer behavior towards more informed and health-centric choices.

  • According to IHME, dietary risks contributed to more than 7 million deaths globally in recent assessments, increasing consumer interest in personalized nutrition strategies designed to support healthier lifestyle choices and long-term disease prevention.

Advancements in Genetic Research

The rapid advancements in genetic research and biotechnology are significantly influencing the Nutrigenomics Market. Innovations in DNA sequencing technologies and bioinformatics have made it feasible to analyze genetic data with unprecedented accuracy. This progress enables the development of more effective nutrigenomic solutions tailored to individual genetic profiles.
 
As research continues to unveil the intricate relationships between genes and nutrition, the market is likely to witness an influx of new products and services. The potential for personalized dietary recommendations based on genetic insights is becoming increasingly appealing to consumers. Consequently, the market is positioned to benefit from these scientific breakthroughs, which may lead to enhanced consumer engagement and market expansion.

  • PubMed research highlights that next-generation sequencing technologies have significantly reduced genomic analysis costs over the past decade, accelerating accessibility and adoption of personalized nutrition and nutrigenomics solutions.

Integration of Technology in Nutrition

The integration of technology into nutrition is transforming the Nutrigenomics Market in profound ways. The proliferation of mobile applications, wearable devices, and online platforms has made it easier for consumers to access personalized nutrition information. These technological advancements facilitate the collection and analysis of genetic data, enabling users to receive tailored dietary recommendations based on their unique genetic profiles.
 
As technology continues to evolve, the market is likely to experience increased engagement from tech-savvy consumers. The convenience and accessibility offered by these innovations may drive higher adoption rates of nutrigenomic solutions. Furthermore, the synergy between technology and nutrition is expected to foster new business models and partnerships, further enhancing the market landscape.

  • According to PubMed, mobile health applications and digital health platforms have demonstrated improved user engagement and adherence to personalized nutrition programs, supporting wider adoption of nutrigenomics services.

Regulatory Support and Standardization

Regulatory support and the push for standardization are becoming increasingly relevant to the Nutrigenomics Market. As the market expands, the need for clear guidelines and regulations to ensure product safety and efficacy is paramount. Governments and regulatory bodies are beginning to recognize the importance of nutrigenomics, leading to the establishment of frameworks that support research and development in this field.
 
This regulatory backing not only enhances consumer trust but also encourages investment in nutrigenomic innovations. Market data suggests that as standardization efforts progress, the market may witness accelerated growth, as companies will be more inclined to develop products that meet established guidelines. This trend indicates a maturation of the market, paving the way for sustainable growth and increased consumer confidence.

  • World Bank data indicate continued growth in biotechnology and life sciences investments globally, supporting regulatory development, research standardization, and innovation across precision nutrition and genetic testing sectors.

Growing Demand for Preventive Healthcare

The shift towards preventive healthcare is emerging as a significant driver for the Nutrigenomics Market. As healthcare systems worldwide increasingly emphasize prevention over treatment, consumers are seeking proactive measures to maintain their health. market offers a unique approach by providing insights into how individual genetic makeup influences nutritional needs.
 
This preventive strategy aligns with the broader trend of personalized medicine, where tailored interventions are prioritized. Market data indicates that the preventive healthcare sector is expanding rapidly, with consumers willing to invest in solutions that promise long-term health benefits. This growing demand for preventive measures is likely to catalyze the adoption of nutrigenomic products and services, thereby propelling the market to new heights.

  • According to the World Bank, global health expenditure exceeded 10% of world GDP in recent years, reflecting increasing investment in preventive healthcare solutions, including personalized nutrition and nutrigenomics-based wellness strategies.

Market Segment Insights

By Application: Personalized Nutrition (Largest) vs. Disease Prevention (Fastest-Growing)

The application segment reveals a significant diversity in Nutrigenomics Market share, accounting for 55% distribution. Personalized Nutrition currently stands out as the largest segment, driven by an increasing demand for tailored dietary recommendations that cater to individual genetic profiles. This approach resonates with health-conscious consumers looking to optimize their nutrition according to their unique biological makeup, leading to greater market penetration compared to other segments. On the other hand, Disease Prevention is recognized as the fastest-growing application within this market. This segment reflects a growing awareness among consumers regarding the role of genetics in health risk reduction. Factors such as rising healthcare costs and a proactive approach towards health management contribute to its rapid advancement, making it an essential area for future research and development in the nutrigenomics landscape.

Nutrigenomix continues expanding its personalized nutrition testing portfolio through evidence-based genetic assessments. Personalized Nutrition accounted for approximately 55% of application revenue in 2024, reflecting strong consumer demand for genetics-driven dietary recommendations and preventive health management solutions.

By End Use: Healthcare (Largest) vs. Dietary Supplements (Fastest-Growing)

The report shows a diverse distribution of Nutrigenomics Market share 60% across various end uses, with healthcare consistently leading the segment. This sector includes personalized medicine and genetic testing, which play pivotal roles in disease prevention and wellness management. Dietary supplements, while presently smaller in share, are rapidly gaining traction as more consumers seek tailored nutritional solutions, thereby shaping the market landscape significantly. As awareness of personalized nutrition increases, so does the demand for dietary supplements formulated based on genetic insights. The pharmaceutical industry is also leveraging nutrigenomics with innovative drug development strategies aiming for precision medication. This convergence of healthcare and dietary supplements reflects a notable trend towards individualized health solutions, indicating a promising future for all stakeholders in this market segment.

DNAfit’s personalized wellness programs support increasing integration of genetic insights into healthcare decision-making. Healthcare represented approximately 60% of end-use revenue in 2024, driven by expanding utilization of genetic testing in disease prevention, wellness management, and precision healthcare initiatives.

By Product Type: Genetic Testing Kits (Largest) vs. Bioinformatics Tools (Fastest-Growing)

The Genetic Testing Kits hold the largest Nutrigenomics Market share of 50%, driven by increasing awareness among consumers about personalized nutrition. These kits enable individuals to uncover genetic predispositions, leading to tailored diet and wellness plans. Bioinformatics Tools, on the other hand, are rapidly gaining traction as they facilitate the analysis of large genomic datasets, transforming the way nutritional data is interpreted and understood. Nutritional Analysis Software follows closely, providing critical insights into nutrient intake and its alignment with genetic profiles. The growth trends in this segment are largely influenced by technological advancements and a surge in health consciousness. As consumers increasingly seek personalized dietary solutions, the demand for Genetic Testing Kits is expected to remain strong. Simultaneously, Bioinformatics Tools are emerging as essential resources for researchers and healthcare professionals, contributing significantly to the advancements in market. This dual drive creates a dynamic environment where both segments thrive, with Genetic Testing Kits dominating and Bioinformatics Tools evolving rapidly to meet the demands of consumers and professionals alike.

Genetic Testing Kits (Dominant) vs. Nutritional Analysis Software (Emerging)

Genetic Testing Kits are at the forefront of the market due to their ability to provide personalized insights into genetic factors that influence dietary choices. These kits are user-friendly and can be conveniently used at home, appealing to a wide consumer base. On the other hand, Nutritional Analysis Software is seen as an emerging player, offering detailed insights into dietary intake based on genetic predispositions. This software acts as an invaluable tool for healthcare providers and nutritionists, enabling them to formulate personalized diet plans. While Genetic Testing Kits are currently dominant, the growth of Nutritional Analysis Software is driven by an increasing demand for data-driven dietary solutions among health-conscious consumers.

By Technology: DNA Sequencing (Largest) vs. Polymerase Chain Reaction (Fastest-Growing)

DNA Sequencing holds the largest Nutrigenomics Market share at 55%, reflecting its widespread adoption and application in personalized nutrition. Following closely is Polymerase Chain Reaction, which has shown remarkable growth due to its versatility and efficiency in genetic analysis. Microarray Analysis, while significant, is currently overshadowed by these two technologies, emphasizing the emerging dynamics in market preferences.

Technology: DNA Sequencing (Dominant) vs. Polymerase Chain Reaction (Emerging)

DNA Sequencing is recognized as the dominant technology in the market, providing comprehensive insights into genetic profiles that personalize dietary recommendations. Its established presence is marked by robust applications across various sectors, including healthcare and research. Conversely, Polymerase Chain Reaction represents the emerging technology, gaining traction for its rapid and accurate amplification of DNA sequences, thereby enabling more detailed genetic investigations. Its growth is fueled by increasing demand for precise genetic testing in nutrition, driving innovations in nutrigenomics research. As these technologies continue to evolve, they reveal distinct pathways for tailored nutritional solutions.

Get more detailed insights about Nutrigenomics Market

Regional Insights

North America : Leading Innovation and Research

North America is the largest market for nutrigenomics, holding approximately 45% of the global share. The region's growth is driven by increasing consumer awareness of personalized nutrition, advancements in genetic testing technologies, and supportive regulatory frameworks. The U.S. and Canada are the primary contributors, with a growing demand for tailored dietary solutions and health optimization strategies.

  • According to CDC data, 6 in 10 U.S. adults live with at least one chronic disease, increasing demand for preventive healthcare solutions and personalized nutrition strategies supported by nutrigenomics technologies.

The competitive landscape is robust, featuring key players like 23andMe, Nutrigenomix, and Genomind. These companies are leveraging cutting-edge research and technology to offer innovative products. The presence of established healthcare systems and a focus on preventive healthcare further enhance market dynamics. As consumer interest in genetic insights continues to rise, the market is expected to expand significantly in the coming years.

  • GE HealthCare invests approximately USD 1 billion annually in research and development, supporting innovation in precision health technologies, advanced diagnostics, and data-driven healthcare solutions that complement nutrigenomics applications.

Europe : Emerging Market with Regulations

Europe is witnessing a significant rise in the market, accounting for approximately 30% of the global share. The growth is fueled by increasing health consciousness among consumers, advancements in biotechnology, and supportive regulations from the European Food Safety Authority (EFSA). Countries like Germany and the UK are leading the charge, with a growing emphasis on personalized nutrition and wellness solutions.

  • According to EMA, the agency evaluates and monitors thousands of medicinal products across the European Union, fostering a strong regulatory environment that supports biotechnology innovation, personalized healthcare development, and consumer confidence in emerging genomic health solutions.

The competitive landscape in Europe is characterized by a mix of established companies and startups. Key players such as DNAfit and market Ltd are at the forefront, offering innovative genetic testing services. The region's regulatory environment encourages research and development, fostering a culture of innovation. As the demand for personalized health solutions grows, the market is poised for further expansion.

Asia-Pacific : Rapid Growth and Potential

Asia-Pacific is emerging as a significant player in the market, holding around 20% of the global share. The region's growth is driven by rising disposable incomes, increasing health awareness, and a growing interest in personalized nutrition. Countries like China and India are at the forefront, with a burgeoning demand for health optimization and dietary customization. The competitive landscape is evolving, with both local and international players entering the market.

Companies such as GenePlanet and market Technologies are expanding their offerings to cater to the diverse needs of consumers. The region's unique dietary habits and cultural diversity present both challenges and opportunities for market players. As the nutrigenomics trend gains traction, the market is expected to witness substantial growth in the coming years.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa region is gradually emerging in the market, currently holding about 5% of the global share. The growth is driven by increasing health awareness, a rise in lifestyle-related diseases, and a growing interest in personalized nutrition solutions. Countries like South Africa and the UAE are leading the market, with a focus on health optimization and dietary customization.

The competitive landscape is still developing, with a mix of local and international players. The presence of key players is limited, but there is a growing interest in genetic testing and personalized health solutions. Challenges such as regulatory hurdles and varying consumer awareness levels may impact growth. However, as the market matures, significant opportunities for expansion are anticipated.

Nutrigenomics Market Regional Image

Key Players and Competitive Insights

The Nutrigenomics Market is currently characterized by a dynamic competitive landscape, driven by increasing consumer awareness regarding the relationship between nutrition and genetics. This awareness is fostering a surge in demand for personalized nutrition solutions, which in turn propels innovation among key players. Companies such as 23andMe (US), Nutrigenomix (CA), and DNAfit (GB) are at the forefront, each adopting distinct strategies to enhance their market positioning. 23andMe (US) focuses on integrating genetic testing with health insights, while Nutrigenomix (CA) emphasizes partnerships with healthcare professionals to promote its services. DNAfit (GB) is leveraging digital platforms to expand its reach, indicating a collective shift towards technology-driven solutions that shape the competitive environment.
 
In terms of business tactics, companies are increasingly localizing their manufacturing processes and optimizing supply chains to enhance efficiency and responsiveness to market demands. The market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is substantial, as they set trends and standards that smaller firms often follow. This competitive structure suggests that while there is room for new entrants, established players are likely to maintain a significant advantage through their established networks and resources.
 
In August 2025, 23andMe (US) announced a strategic partnership with a leading health insurance provider to offer genetic testing as part of preventive health measures. This collaboration is poised to enhance the accessibility of nutrigenomic insights to a broader audience, potentially increasing consumer engagement and driving revenue growth. The strategic importance of this partnership lies in its ability to integrate genetic testing into mainstream healthcare, thereby legitimizing the role of nutrigenomics in preventive health strategies.
 
In September 2025, Nutrigenomix (CA) launched a new line of personalized nutrition products tailored for athletes, which underscores its commitment to innovation in the sports nutrition segment. This move not only diversifies its product offerings but also positions the company to capitalize on the growing trend of health-conscious consumers seeking performance-enhancing dietary solutions. The launch reflects a strategic pivot towards niche markets, which may yield higher margins and foster brand loyalty among specific consumer segments.
 
In October 2025, DNAfit (GB) unveiled an AI-driven platform that provides real-time dietary recommendations based on genetic data. This technological advancement signifies a critical step towards personalized nutrition, as it allows users to receive tailored advice that adapts to their lifestyle changes. The strategic importance of this development lies in its potential to enhance user engagement and retention, as consumers increasingly seek personalized solutions that evolve with their needs.
 
As of October 2025, the market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming increasingly pivotal, as companies collaborate to enhance their technological capabilities and expand their market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize these elements will be better positioned to thrive in an increasingly competitive landscape.

Key Companies in the Nutrigenomics Market include

Industry Developments

Recent developments in the Global Nutrigenomics Market have shown significant growth and innovation among key players such as Wellness Within, Metagenics, and Nutrigenomix. In September 2023, Nutraceutical International Corporation further expanded its portfolio by acquiring nutritional product lines, enhancing its offerings in nutrigenomics. The global market is witnessing a rising demand for personalized nutrition, driven by advances in DNA analysis technologies, which has been pivotal in shaping product development strategies among companies like DNAfit and 23andMe. Furthermore, the collaboration of Genetics Unlocked and Genomatix in August 2022 to develop tools for genomic research has strengthened their market position.

The valuation of the nutrigenomics sector continues to rise, with estimates projecting significant growth due to increasing consumer awareness regarding health and wellness. In the past couple of years, events like the partnership between Youngevity International and Nutritional Genomics in May 2021 have also been crucial in enhancing data analytics and tailored nutrition solutions. Major happenings in this evolving market indicate a competitive landscape that is poised for substantial advancements in research and product innovation in the near future.

Future Outlook

Nutrigenomics Market Future Outlook

The Nutrigenomics Market size is projected to reach USD 4.008 Billion by 2035, growing at a CAGR of 17.5%, driven by advancements in personalized nutrition, increasing health awareness, and technological innovations.

New opportunities lie in:

  • Development of personalized dietary supplements based on genetic profiles. Integration of AI-driven analytics for customized nutrition plans. Expansion of nutrigenomics testing services in healthcare facilities.

By 2035, the Nutrigenomics Market is expected to be a pivotal sector in personalized health solutions.

Market Segmentation

Nutrigenomics Market End Use Outlook

  • Healthcare
  • Dietary Supplements
  • Food
  • Beverage
  • Pharmaceuticals

Nutrigenomics Market Technology Outlook

  • DNA Sequencing
  • Microarray Analysis
  • Polymerase Chain Reaction

Nutrigenomics Market Application Outlook

  • Personalized Nutrition
  • Disease Prevention
  • Health Optimization
  • Fitness and Athletic Performance

Nutrigenomics Market Product Type Outlook

  • Genetic Testing Kits
  • Bioinformatics Tools
  • Nutritional Analysis Software

Report Scope

MARKET SIZE 2024 0.68(USD Billion)
MARKET SIZE 2025 0.799(USD Billion)
MARKET SIZE 2035 4.008(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 17.5% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Nutrigenomix (CA), DNAfit (GB), 23andMe (US), Genomind (US), Nutrigenomics Ltd (GB), Nutrigenomix Inc (CA), Genetic Health (US), Nutrigenomics Technologies (US)
Segments Covered Application, End Use, Product Type, Technology, Regional
Key Market Opportunities Integration of personalized nutrition solutions driven by advancements in genetic testing technologies.
Key Market Dynamics Rising consumer interest in personalized nutrition drives innovation and competition in the Nutrigenomics Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the market by 2035?

The market is projected to reach a valuation of 4.008 USD Billion by 2035.

What was the market valuation of the market in 2024?

In 2024, the market had a valuation of 0.68 USD Billion.

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 17.5%.

Which application segment is anticipated to grow the most in the Nutrigenomics Market?

The Personalized Nutrition application segment is anticipated to grow from 0.2 USD Billion in 2024 to 1.2 USD Billion by 2035.

What are the key players in the Nutrigenomics Market?

Key players in the Nutrigenomics Market include Nutrigenomix, DNAfit, 23andMe, Genomind, and Nutrigenomics Ltd.

How does the Disease Prevention segment perform in the market?

The Disease Prevention segment is expected to grow from 0.15 USD Billion in 2024 to 0.9 USD Billion by 2035.

What product type is projected to have the highest growth in the market?

Genetic Testing Kits are projected to grow from 0.25 USD Billion in 2024 to 1.5 USD Billion by 2035.

What end-use segment is expected to see significant growth in the market?

The Healthcare end-use segment is expected to grow from 0.2 USD Billion in 2024 to 1.2 USD Billion by 2035.

Which technology segment is likely to dominate the Nutrigenomics Market?

The Polymerase Chain Reaction technology segment is likely to grow from 0.28 USD Billion in 2024 to 1.6 USD Billion by 2035.

What is the growth outlook for the Nutrigenomics Market in the coming years?

The growth outlook for the Nutrigenomics Market appears robust, with a projected valuation increase to 4.008 USD Billion by 2035.

Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, genomic research repositories, peer-reviewed nutritional science journals, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA), European Food Safety Authority (EFSA), US Federal Trade Commission (FTC), National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, World Health Organization (WHO) Global Health Observatory, Organisation for Economic Co-operation and Development (OECD) Health Statistics, European Commission Joint Research Centre (JRC), International Society of Nutrigenetics/Nutrigenomics (ISNN), Academy of Nutrition and Dietetics, Human Genome Project archives, and national genomic databases from key markets. These sources were utilized to collect genetic testing volume statistics, regulatory approval data for direct-to-consumer (DTC) genetic tests, clinical validation studies on gene-diet interactions, population genomic prevalence data, obesity and metabolic disorder epidemiology, sequencing cost trends, and personalized nutrition adoption metrics across reagents/kits, genetic testing services, and nutraceutical applications.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. Supply-side sources consist of CEOs, Chief Scientific Officers (CSOs), VPs of Genomics, regulatory affairs heads, bioinformatics directors, and commercial leaders from nutrigenomics testing companies, personalized nutrition platforms, genomic assay manufacturers, and functional food developers. Registered dietitian nutritionists (RDNs), clinical genomics specialists, metabolic disorder clinicians, medical directors of corporate wellness programs, procurement officers from hospitals and diagnostic laboratories, and research scientists from academic nutrigenomics centers comprised demand-side sources. Primary research has confirmed the timelines of genetic testing pipelines, validated market segmentation across obesity management, cardiovascular health, and metabolic disorder applications, and gathered insights on the clinical adoption of personalized nutrition protocols, DTC pricing strategies, bioinformatics platform integration, and regulatory compliance for gene-based health claims.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping and genetic testing volume analysis. The methodology included:

Identification of 50+ key manufacturers and service providers across North America, Europe, Asia-Pacific, and Latin America specializing in genetic testing kits, reagents, bioinformatics platforms, and personalized nutrition services

Product mapping across gene panels for macronutrient metabolism, micronutrient absorption, food intolerance, obesity risk, cardiovascular markers, and sports performance categories

Analysis of reported and modeled annual revenues specific to nutrigenomics portfolios, including DTC testing subscriptions and clinical diagnostic services

Coverage of manufacturers and service providers representing 75-80% of global market share in 2024

Extrapolation using bottom-up (genetic test volume × ASP by country/region) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations across testing kits, nutritional supplements, and digital health platforms

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.